US Stock MarketDetailed Quotes

Armata Pharmaceuticals (ARMP)

Watchlist
  • 13.910
  • -0.890-6.01%
Close Apr 22 16:00 ET
  • 13.910
  • 0.0000.00%
Post 20:01 ET
509.56MMarket Cap-2.90P/E (TTM)

Armata Pharmaceuticals (ARMP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.43%31.22M
-20.19%8.41M
-20.30%7.78M
-42.55%6.84M
-19.92%8.19M
3.78%42.44M
10.02%10.54M
-5.61%9.76M
23.73%11.91M
-9.85%10.23M
Selling and administrative expenses
-5.88%12.41M
3.10%3.43M
-4.10%3.11M
-23.84%2.62M
2.36%3.25M
13.18%13.18M
4.53%3.32M
-9.46%3.24M
46.34%3.44M
25.22%3.18M
-General and administrative expense
-5.88%12.41M
3.10%3.43M
-4.10%3.11M
-23.84%2.62M
2.36%3.25M
13.18%13.18M
4.53%3.32M
-9.46%3.24M
46.34%3.44M
25.22%3.18M
Research and development costs
-31.11%23.72M
-28.17%6.07M
-38.60%5.82M
-24.55%6.39M
-32.27%5.43M
1.94%34.43M
6.60%8.45M
18.89%9.49M
2.62%8.48M
-16.53%8.02M
Other operating expenses
5.22%-4.9M
12.15%-1.09M
61.02%-1.16M
---2.17M
49.17%-491K
-14.24%-5.17M
19.18%-1.24M
-142.69%-2.97M
----
-21.36%-966K
Operating profit
26.43%-31.22M
20.19%-8.41M
20.30%-7.78M
42.55%-6.84M
19.92%-8.19M
-3.78%-42.44M
-10.02%-10.54M
5.61%-9.76M
-23.73%-11.91M
9.85%-10.23M
Net non-operating interest income expense
-61.29%-16.2M
-49.30%-4.7M
-61.89%-4.26M
-48.18%-3.7M
-100.40%-3.54M
-310.50%-10.05M
-127.93%-3.15M
-132.86%-2.63M
-5,528.26%-2.5M
-9,922.22%-1.77M
Non-operating interest income
-44.33%388K
0.77%131K
-69.39%90K
-51.13%108K
13.46%59K
289.39%697K
91.18%130K
525.53%294K
380.43%221K
188.89%52K
Non-operating interest expense
54.44%16.59M
47.38%4.83M
48.68%4.35M
40.10%3.81M
97.91%3.6M
309.06%10.74M
126.21%3.28M
148.55%2.92M
--2.72M
--1.82M
Other net income (expense)
-476.51%-126.38M
-782.57%-111.18M
-312.09%-14.64M
-124.58%-5.75M
139.95%5.2M
230.56%33.57M
283.31%16.29M
135.05%6.9M
287.62%23.4M
-311.92%-13.03M
Special income (charges)
-349.86%-5.41M
----
----
----
----
156.07%2.17M
--2.17M
--0
----
----
-Less:Other special charges
----
----
----
----
----
-156.07%-2.17M
----
----
----
----
-Write off
--5.41M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-485.24%-120.96M
-848.93%-105.77M
-312.09%-14.64M
-124.58%-5.75M
139.95%5.2M
243.74%31.4M
258.94%14.12M
143.61%6.9M
287.62%23.4M
-311.92%-13.03M
Income before tax
-818.79%-173.8M
-4,880.69%-124.3M
-386.68%-26.68M
-281.34%-16.3M
73.90%-6.53M
72.60%-18.92M
113.10%2.6M
82.41%-5.48M
353.34%8.99M
-72.68%-25.02M
Income tax
Net income
-818.79%-173.8M
-4,880.69%-124.3M
-386.68%-26.68M
-281.34%-16.3M
73.90%-6.53M
72.60%-18.92M
113.10%2.6M
82.41%-5.48M
353.34%8.99M
-72.68%-25.02M
Net income continuous Operations
-818.79%-173.8M
-4,880.69%-124.3M
-386.68%-26.68M
-281.34%-16.3M
73.90%-6.53M
72.60%-18.92M
113.10%2.6M
82.41%-5.48M
353.34%8.99M
-72.68%-25.02M
Minority interest income
Net income attributable to the parent company
-818.79%-173.8M
-4,880.69%-124.3M
-386.68%-26.68M
-281.34%-16.3M
73.90%-6.53M
72.60%-18.92M
113.10%2.6M
82.41%-5.48M
353.34%8.99M
-72.68%-25.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-818.79%-173.8M
-4,880.69%-124.3M
-386.68%-26.68M
-281.34%-16.3M
73.90%-6.53M
72.60%-18.92M
113.10%2.6M
82.41%-5.48M
353.34%8.99M
-72.68%-25.02M
Basic earnings per share
-823.08%-4.8
-5,000.00%-3.43
-393.33%-0.74
-280.00%-0.45
73.91%-0.18
72.77%-0.52
112.73%0.07
82.56%-0.15
350.00%0.25
-72.50%-0.69
Diluted earnings per share
-439.33%-4.8
-1,391.30%-3.43
-393.33%-0.74
-80.00%-0.45
71.01%-0.2
53.40%-0.89
58.18%-0.23
82.56%-0.15
-47.06%-0.25
-72.50%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.43%31.22M-20.19%8.41M-20.30%7.78M-42.55%6.84M-19.92%8.19M3.78%42.44M10.02%10.54M-5.61%9.76M23.73%11.91M-9.85%10.23M
Selling and administrative expenses -5.88%12.41M3.10%3.43M-4.10%3.11M-23.84%2.62M2.36%3.25M13.18%13.18M4.53%3.32M-9.46%3.24M46.34%3.44M25.22%3.18M
-General and administrative expense -5.88%12.41M3.10%3.43M-4.10%3.11M-23.84%2.62M2.36%3.25M13.18%13.18M4.53%3.32M-9.46%3.24M46.34%3.44M25.22%3.18M
Research and development costs -31.11%23.72M-28.17%6.07M-38.60%5.82M-24.55%6.39M-32.27%5.43M1.94%34.43M6.60%8.45M18.89%9.49M2.62%8.48M-16.53%8.02M
Other operating expenses 5.22%-4.9M12.15%-1.09M61.02%-1.16M---2.17M49.17%-491K-14.24%-5.17M19.18%-1.24M-142.69%-2.97M-----21.36%-966K
Operating profit 26.43%-31.22M20.19%-8.41M20.30%-7.78M42.55%-6.84M19.92%-8.19M-3.78%-42.44M-10.02%-10.54M5.61%-9.76M-23.73%-11.91M9.85%-10.23M
Net non-operating interest income expense -61.29%-16.2M-49.30%-4.7M-61.89%-4.26M-48.18%-3.7M-100.40%-3.54M-310.50%-10.05M-127.93%-3.15M-132.86%-2.63M-5,528.26%-2.5M-9,922.22%-1.77M
Non-operating interest income -44.33%388K0.77%131K-69.39%90K-51.13%108K13.46%59K289.39%697K91.18%130K525.53%294K380.43%221K188.89%52K
Non-operating interest expense 54.44%16.59M47.38%4.83M48.68%4.35M40.10%3.81M97.91%3.6M309.06%10.74M126.21%3.28M148.55%2.92M--2.72M--1.82M
Other net income (expense) -476.51%-126.38M-782.57%-111.18M-312.09%-14.64M-124.58%-5.75M139.95%5.2M230.56%33.57M283.31%16.29M135.05%6.9M287.62%23.4M-311.92%-13.03M
Special income (charges) -349.86%-5.41M----------------156.07%2.17M--2.17M--0--------
-Less:Other special charges ---------------------156.07%-2.17M----------------
-Write off --5.41M------------------0----------------
Other non- operating income (expenses) -485.24%-120.96M-848.93%-105.77M-312.09%-14.64M-124.58%-5.75M139.95%5.2M243.74%31.4M258.94%14.12M143.61%6.9M287.62%23.4M-311.92%-13.03M
Income before tax -818.79%-173.8M-4,880.69%-124.3M-386.68%-26.68M-281.34%-16.3M73.90%-6.53M72.60%-18.92M113.10%2.6M82.41%-5.48M353.34%8.99M-72.68%-25.02M
Income tax
Net income -818.79%-173.8M-4,880.69%-124.3M-386.68%-26.68M-281.34%-16.3M73.90%-6.53M72.60%-18.92M113.10%2.6M82.41%-5.48M353.34%8.99M-72.68%-25.02M
Net income continuous Operations -818.79%-173.8M-4,880.69%-124.3M-386.68%-26.68M-281.34%-16.3M73.90%-6.53M72.60%-18.92M113.10%2.6M82.41%-5.48M353.34%8.99M-72.68%-25.02M
Minority interest income
Net income attributable to the parent company -818.79%-173.8M-4,880.69%-124.3M-386.68%-26.68M-281.34%-16.3M73.90%-6.53M72.60%-18.92M113.10%2.6M82.41%-5.48M353.34%8.99M-72.68%-25.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -818.79%-173.8M-4,880.69%-124.3M-386.68%-26.68M-281.34%-16.3M73.90%-6.53M72.60%-18.92M113.10%2.6M82.41%-5.48M353.34%8.99M-72.68%-25.02M
Basic earnings per share -823.08%-4.8-5,000.00%-3.43-393.33%-0.74-280.00%-0.4573.91%-0.1872.77%-0.52112.73%0.0782.56%-0.15350.00%0.25-72.50%-0.69
Diluted earnings per share -439.33%-4.8-1,391.30%-3.43-393.33%-0.74-80.00%-0.4571.01%-0.253.40%-0.8958.18%-0.2382.56%-0.15-47.06%-0.25-72.50%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 22 Beijing time, reports indicated that Trump agreed to extend the ceasefire between the US and Iran by 3-5 days rather than indefi Show More